Document Detail

The influence of parity and gravidity on first trimester markers of chromosomal abnormality.
MedLine Citation:
PMID:  11038455     Owner:  NLM     Status:  MEDLINE    
We have studied changes in first trimester fetal nuchal translucency (NT) and maternal serum free beta-hCG and PAPP-A with gravidity and parity in 3252 singleton pregnancies unaffected by chromosomal abnormality or major pregnancy complications. We have shown that gravidity and parity is associated with a small but progressive decrease in fetal NT and a small but progressive increase in free beta-hCG and PAPP-A. None of these small changes with increasing gravidity or parity are statistically significant and hence correction for these variables is not necessary when considering first trimester screening for chromosomal abnormalities.
K Spencer; C Y Ong; A W Liao; K H Nicolaides
Related Documents :
2464935 - Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of h...
22807155 - A prospective study evaluating the performance of first trimester combined screening fo...
11236115 - Expectant management of early pregnancies of unknown location: a prospective evaluation...
16963045 - Correlation between first-trimester uterine artery doppler indices and maternal serum f...
23422685 - Exposure to organochlorines and mercury through fish and marine mammal consumption: ass...
19573085 - Do embryos influence maternal investment? evaluating maternal-fetal coadaptation and th...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  20     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-11-08     Completed Date:  2000-12-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  792-4     Citation Subset:  IM    
Copyright Information:
Copyright 2000 John Wiley & Sons, Ltd.
Endocrine Unit, Clinical Biochemistry Department, Harold Wood Hospital, Gubbins Lane, Romford, Essex RM3 0BE, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Chorionic Gonadotropin, beta Subunit, Human / blood*
Down Syndrome / diagnosis*
Mass Screening / methods,  standards
Maternal Age
Pregnancy Trimester, First
Pregnancy-Associated Plasma Protein-A / metabolism*
Prenatal Diagnosis*
Ultrasonography, Prenatal
Reg. No./Substance:
0/Biological Markers; 0/Chorionic Gonadotropin, beta Subunit, Human; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG.
Next Document:  Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses.